NOV 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/220233

Contents of this Issue


Page 49 of 122

Optimize Care, Enhance Yo Practice Care, Your Practice our Improve Improve Lipid Secretions, Increase Comfort, Satisfy Patients Secretions, Increase Comfor Comfort, Patients Recognize the Impact of Meibomian Gland Dysfunction, Seize the Opportunity "TearScience® gives us another weapon in our arsenal to treat dry eye and stabilize the tear flm. It has been gratifying to help patients frustrated with the results of traditional therapies." Alex Cohen, MD, PhD Dean McGee Eye Institute Oklahoma City, OK LipiFlow® is clinically proven and the only currently available medical device indicated for Meibomian Gland Dysfunction (MGD). Visit tearscience.com for complete product and safety information. LipiFlow® and LipiView® are registered trademarks of TearScience®, Inc. Copyright - TearScience® - The Evaporative Dry Eye Experts. All rights reserved. 13-ADV-120 REV A

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - NOV 2013